King Vision® and GlideScope® in Difficult Airways

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

November 17, 2015

Study Completion Date

December 17, 2015

Conditions
Airway Management
Interventions
DEVICE

Video laryngoscopes

Patients were randomized into one of the three groups through a computer generated randomization schedule. Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade. Patients will only be tested with one device. All patients will be intubated using a conventional ETT.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

King Systems Corporation

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT03685968 - King Vision® and GlideScope® in Difficult Airways | Biotech Hunter | Biotech Hunter